ANDE - The Andersons, Inc.
NASDAQ
->
Consumer Defensive
->
Food Distribution
Maumee,
United States
Type: Equity
ANDE price evolution
ANDE
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $530.39 | $283.9 | $643.85 | |
| Short term investments | ||||
| Net receivables | $756.62 | $743.55 | $701.71 | $762.55 |
| Inventory | $884.34 | $686.54 | $994.54 | $1166.7 |
| Total current assets | $2331.07 | $2249.3 | $2213.91 | $2806.96 |
| Long term investments | ||||
| Property, plant & equipment | $709.95 | $694.14 | $741.65 | $747.6 |
| Goodwill & intangible assets | $208.38 | $213.44 | ||
| Total noncurrent assets | $1050.51 | $1047.16 | $1048.04 | |
| Total investments | ||||
| Total assets | $3388.3 | $3299.81 | $3261.07 | $3855.01 |
| Current liabilities | ||||
| Accounts payable | $774.35 | $607.08 | $625.84 | $1055.47 |
| Deferred revenue | $124.42 | $174.65 | $187.05 | |
| Short long term debt | $31.69 | $37.77 | $70.67 | |
| Total current liabilities | $1177.87 | $1084.73 | $1083.28 | $1636.33 |
| Long term debt | $542.56 | $549.38 | $587.4 | $594.62 |
| Total noncurrent liabilities | $694.82 | $702.14 | $702.29 | |
| Total debt | $581.07 | $625.16 | $665.29 | |
| Total liabilities | $2059.13 | $1779.55 | $1785.42 | $2338.62 |
| Shareholders' equity | ||||
| Retained earnings | $932.22 | $911.46 | $881.91 | $882.94 |
| Other shareholder equity | $15.12 | $21.18 | $23.41 | $22.86 |
| Total shareholder equity | $1310.6 | $1279.99 | $1282.9 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $643.85 | $115.27 | $216.44 | $29.12 |
| Short term investments | ||||
| Net receivables | $762.55 | $1248.88 | $835.18 | $659.83 |
| Inventory | $1166.7 | $1731.72 | $1814.54 | $1300.69 |
| Total current assets | $2806.96 | $3465.95 | $3372.33 | $2416.41 |
| Long term investments | ||||
| Property, plant & equipment | $747.6 | $824.62 | $838.17 | $1527.16 |
| Goodwill & intangible assets | $213.44 | $230.25 | $246.48 | $278.65 |
| Total noncurrent assets | $1048.04 | $1142.04 | $1196.89 | $1855.71 |
| Total investments | ||||
| Total assets | $3855.01 | $4608 | $4569.22 | $4272.12 |
| Current liabilities | ||||
| Accounts payable | $1055.47 | $1423.63 | $1199.32 | $957.68 |
| Deferred revenue | $187.05 | $370.52 | $358.12 | $180.16 |
| Short long term debt | $70.67 | $382.73 | $534.05 | $479.18 |
| Total current liabilities | $1636.33 | $2521.32 | $2463.93 | $1931.68 |
| Long term debt | $594.62 | $492.52 | $631.81 | $953.72 |
| Total noncurrent liabilities | $702.29 | $656.9 | $797.59 | $1179.78 |
| Total debt | $665.29 | $912.39 | $1165.86 | $1432.89 |
| Total liabilities | $2338.62 | $3409.39 | $3261.51 | $3111.46 |
| Shareholders' equity | ||||
| Retained earnings | $882.94 | $807.77 | $702.76 | $626.08 |
| Other shareholder equity | $22.86 | $28.69 | $1.19 | -$12.08 |
| Total shareholder equity | $1282.9 | $1198.6 | $1072.42 | $961.89 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2620.99 | $2718.22 | $3213 | |
| Cost of revenue | $2589.9 | $2995.29 | ||
| Gross Profit | $177.13 | $128.32 | $217.71 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $119.36 | $132.71 | ||
| Total operating expenses | $120.49 | $119.36 | $132.71 | |
| Operating income | $8.96 | $85 | ||
| Income from continuing operations | ||||
| EBIT | $13.41 | $72.61 | ||
| Income tax expense | $10.73 | $1.3 | $13.32 | |
| Interest expense | -$0.22 | $6.52 | $8.1 | |
| Net income | ||||
| Net income | $27.36 | $5.58 | $51.19 | |
| Income (for common shares) | $5.58 | $51.19 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14750.11 | $17325.38 | $12612.05 | $8208.44 |
| Cost of revenue | $14004.75 | $16641.22 | $12019.35 | $7803.51 |
| Gross Profit | $745.36 | $684.16 | $592.7 | $404.92 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $492.26 | $466.56 | $423.75 | $399.21 |
| Total operating expenses | $579.42 | $466.56 | $432.07 | $399.21 |
| Operating income | $165.95 | $217.61 | $160.62 | $5.71 |
| Income from continuing operations | ||||
| EBIT | $185.09 | $227.56 | $170.51 | $48.73 |
| Income tax expense | $37.03 | $39.63 | $29.23 | -$10.26 |
| Interest expense | $46.87 | $56.85 | $37.29 | $51.27 |
| Net income | ||||
| Net income | $101.19 | $131.08 | $103.99 | $7.71 |
| Income (for common shares) | $101.19 | $131.08 | $103.99 | $7.71 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $35.98 | $5.58 | $51.19 | |
| Operating activities | ||||
| Depreciation | $30.27 | $30.95 | $31.31 | |
| Business acquisitions & disposals | -$9.56 | -$0.31 | ||
| Stock-based compensation | $12.86 | |||
| Total cash flows from operations | $304.43 | -$239.63 | $250.66 | |
| Investing activities | ||||
| Capital expenditures | -$28.61 | -$26.77 | -$41.3 | |
| Investments | -$1.73 | |||
| Total cash flows from investing | -$90.59 | -$36.09 | -$22.05 | -$36.62 |
| Financing activities | ||||
| Dividends paid | -$19.47 | -$6.48 | -$6.52 | -$6.6 |
| Sale and purchase of stock | ||||
| Net borrowings | -$12.67 | -$38.78 | $21.34 | |
| Total cash flows from financing | -$162.59 | -$21.65 | -$98.28 | $11.85 |
| Effect of exchange rate | $0.7 | -$0.22 | $0.01 | -$0.1 |
| Change in cash and equivalents | -$189.79 | $246.48 | -$359.95 | $225.8 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $101.19 | $131.08 | $103.99 | $7.71 |
| Operating activities | ||||
| Depreciation | $125.11 | $134.74 | $178.93 | $188.64 |
| Business acquisitions & disposals | -$14.38 | $41.23 | $549.81 | $11.11 |
| Stock-based compensation | $12.86 | $11.19 | $11.04 | $10.18 |
| Total cash flows from operations | $946.75 | $287.12 | -$51.05 | -$74.43 |
| Investing activities | ||||
| Capital expenditures | -$144.07 | -$97.73 | -$58.15 | -$94.81 |
| Investments | -$1.73 | -$2.1 | -$6.24 | -$3.06 |
| Total cash flows from investing | -$153.88 | -$52.9 | $487.25 | -$86.76 |
| Financing activities | ||||
| Dividends paid | -$25.37 | -$24.61 | -$23.75 | -$23 |
| Sale and purchase of stock | -$1.75 | -$7.7 | $6.67 | |
| Net borrowings | -$183.32 | -$259.43 | -$236.32 | $166.27 |
| Total cash flows from financing | -$263.99 | -$334.73 | -$248.77 | $136.3 |
| Effect of exchange rate | -$0.29 | -$0.66 | -$0.11 | -$0.88 |
| Change in cash and equivalents | $528.59 | -$101.17 | $187.32 | -$25.77 |
News
|
Atria Wealth Solutions Inc. Acquires 35 Shares of TransDigm Group Incorporated...
ETF DAILY NEWS
25 Feb 2025
|
|
Church & Dwight Co., Inc. (NYSE:CHD) Shares Acquired by CIBC Asset Management...
ETF DAILY NEWS
20 Feb 2025
|
|
Andersons (NASDAQ:ANDE) Shares Gap Up on Earnings Beat
ETF DAILY NEWS
20 Feb 2025
|
|
Kayne Anderson BDC secures enhanced credit facility terms By Investing.com
Investing.com
19 Feb 2025
|
|
Andersons (ANDE) to Release Quarterly Earnings on Tuesday
ETF DAILY NEWS
17 Feb 2025
|
|
Andersons' (NASDAQ:ANDE) Dividend Will Be $0.195
Simply Wall St. · via Yahoo Finance
16 Feb 2025
|
|
Psst: I Found the Old-School Beauty Fave Behind Sabrina Carpenter's Grammys Glam
PureWow · via Yahoo News
3 Feb 2025
|
|
Compass Therapeutics Stock Skyrockets 108% in a Month: Here's Why
Zacks
30 Jan 2025
|
|
Waste Connections, Inc. (NYSE:WCN) Shares Sold by Janney Montgomery Scott LLC
ETF DAILY NEWS
30 Jan 2025
|
|
One Couchbase Insider Raised Stake By 67% In Previous Year
Simply Wall St. · via Yahoo Finance
29 Jan 2025
|
Fundamentals
| Market cap | $1.59B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 34.07M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -27.91% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.82 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.98 |
| Quick ratio | 1.23 |